Eviva® Breast Biopsy System

Designed with enhanced technology, the system combines optimised patient access with seamless integration for a compassionate, minimally invasive breast biopsy.

Breast Biopsy System on white background

    Overview

    Documents

    Training

    Taking Breast Biopsy to a Higher Standard

    The Eviva Breast Biopsy System was designed with the flagship technology of the Hologic ATEC® Breast Biopsy Device, with additional features for optimal use during stereotactic or 3D biopsy procedures. Listening to physicians and technologists about the women they treat is the foundation for the device’s innovative design. Breast biopsies using Eviva provides clinicians with high quality core samples.1

    All Eviva Breast Biopsy Systems work with the ATEC Breast Biopsy System. Stereotactic kits are also available for use with competitive systems.

    Trusted Globally

    Proven technology designed to deliver a fast, compassionate, and easy breast biopsy.5

    Fast & Easy

    Remove consistent cores in under 30 seconds with 4.5 second biopsy cycle time.2

    Easy set up and clean up.

    Optimise access to challenging lesions close to the chest wall using a low-profile needle.

    Manage thin breast compressions as small as 19mm.3

    Compassionate

    Manage patient pain by automatically applying local anaesthetic directly to the biopsy site with every core, via the patented Y-valve.4

    Minimises complications and maximises patient satisfaction.5

    Quiet, remote firing for greater physician-patient interaction.5

    Patient Access

    Optimised access to challenging lesions.

    Biopsy needle options for most breast sizes.

    Saline lavage and constant aspiration to assist in consistent core retrieval, and to minimise pain and bleeding.

    Seamless Integration

    One unified system for biopsy and site marking.

    Easily delivers local anaesthetic directly to the biopsy site during every cycle without interruption.

    No software required to program or operate the console.

    Unlock the Advantage of Time

    The Breast Health Continuum of Care offers integrated solutions for clinical confidence, workflow efficiency and compassionate patient care. It gives more women, more time in better health.

    The Eviva Breast Biopsy System is part of the Hologic Biopsy Solution.

    Illustration of Hologic Breast Health Continuum of Care with Radiology

    Improved Patient Experience

    When it comes to what’s important, 9 out of 10 clinicians agree the Eviva device offers a better patient experience compared to other vacuum assisted breast biopsy devices.5

    Acquires high quality core samples

    Minimises complications and maximises patient satisfaction

    Easy-to-operate

    Breast biopsy device and needle

    Eviva Breast Biopsy Family of Devices

    With its multiple 9G and 12G needle options, the Eviva breast biopsy system enables access to more patients. 

    • Standard Eviva Biopsy Device: 9 or 12 gauge, 10 or 13 cm length, 20 mm aperture, 23 mm throw/stroke
    • Trocar Petite Eviva Biopsy Device (for min compression of 20 mm): 9 gauge, 10 or 13 cm length, 12 mm aperture, 15 mm throw/stroke
    • Blunt Nose Petite Eviva Biopsy Device (hemispherical tip, for min compression of 19mm): 9 gauge, 10 or 13 cm length, 12 mm aperture

    Visit Our Virtual Hospital

    Browse our portfolio of Breast Health solutions in 3D. See how you can unlock the advantage of time across the entire Breast Continuum of Care. 

    Image rendering of Breast Biopsy Suite

    A Comprehensive Range of Compatible Breast Biopsy Markers

    The Hologic range of biopsy site markers for use with the Eviva Breast Biopsy Device come in multiple shapes, gauges and lengths. All markers come with  blunt tip deployment and an ergonomic and easy to use deployment device included.

    Intelligently designed to provide long-term ultrasound visibility, all Tumark markers are non-bioabsorbable, biocompatible permanent markers offering excellent visibility under mammography at deployment and are designed to minimise movement.6

    Video Gallery

    Patient Experience in Stereotactic & 3D Breast Biopsy

    Because Hologic recognises the anxiety women have when facing a breast biopsy, we are committed to focusing on creating a better patient experience with the products we provide. Eviva was designed for use with the advanced prone and upright Affirm™ Breast Biopsy Guidance Systems, offering optimised access.

    • With the ability to biopsy to a minimum breast compression of 19mm, Eviva gives more women an alternative to open surgical biopsy.3
    • It also offers patients a positive cosmetic outcome post-biopsy, with maximised core retrieval and minimal incision size.5
    Patient speaking with healthcare professional

    Evidence. Insight. Collaboration.

    Our education portal improves patient care through excellence in education, communication of clinical and scientific evidence, and partnerships with the healthcare community.

    Insights

    Female patient waiting

    Transforming Women's Healthcare with AI

    Putting women at the heart of the 10 year cancer plan

    Putting Women at the Heart of the 10-Year Cancer Plan

    A Vision for Women-centric Care

    A Vision for Women-centric Care

      1. Hologic Data On File: MISC-06068, Rev 001. Eviva Audit, 155 respondents comprised of radiologists, RAD Admins, Directors of Radiology, and Breast Surgeons. Identifying Optimal Claims for the Eviva Breast Biopsy Device, July 2015. Kadence International report released April, 2020
      2. Hologic data on file, VER-03567, Rev 001
      3. Hologic data on file, VER-05759, VER-04202, VER-04111, VER-03205, VER-03792, DHM-02115, DHM-02203.
      4. Hologic data on file, AW-02708 - Instructions for use - Eviva - Stereotactic guided breast biopsy system.
      5. Hologic data on file, MISC-06068, Attachment 1 Kadence study, “Eviva Audit – Identifying optimal claims for the Eviva Breast Biopsy device”, July 2015.
      6. Tumark® Marker Data Collection Study, 2017, DHM-06169, 3 clinicians at 3 hospitals for 90 marker placements, 2017.
      7. Hologic Data on File: MISC-07876, Rev 001 attachment 2
      8. Hologic Data on File: VER-07555, Rev 001
      9. Yen P, Dumas S, Albert A, et al. Post-Vacuum-Assisted Stereotactic Core Biopsy Clip Displacement: A Comparison Between Commercially Available Clips and Surgical Clip. Can Assoc Radiol J. 2018 Feb;69(1):10-15. doi: 10.1016/j.carj.2017.08.004. PMID: 29458952. Devices show reduced displacement when compared to traditional metal surgical clips (28% and 27% vs 38% displacement, p = 0.001 and p = 0.0001). Visibility is dependent on surrounding tissue, experience may vary.
      10. Pinkney DM, Shah BA. Prospective Comparative Study to Evaluate the Sonographic Visibility of Five Commercially Available Breast Biopsy Markers. Journal of Diagnostic Medical Sonography. 2013;29(4):151-158. doi:10.1177/8756479313486962. *45.4 % of respondence rated SecurMark high sonographic visibility after 6-weeks post procedure, 4x more than the Gel Mark UltraCor™

      Safety Data Sheets

      Package Inserts

      2797
      0482

      Hologic BV, Da Vincilaan 5, 1930 Zaventem, Belgium.

      Notified Body number wherever applicable
      EC Representative Information wherever applicable